In particular, BRCA1 and BRCA2 loss of function have been shown to lead to dysfunctional HR in cancer cells [15, 18] whereas the association between PTEN loss of function and dysfunctional HR is more controversial [19]. The gene discussed is PTEN; the disease is cancer.